id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02174549
|
15:31:cancer,35:45:cancer,47:66:cancer,96:123:cancer
|
Unresectable, locally advanced or metastatic, well differentiated (low or intermediate grade), neuroendocrine tumors (NET)
| 3
|
[
"Unresectable",
",",
"locally",
"advanced",
"or",
"metastatic",
",",
"well",
"differentiated",
"(",
"low",
"or",
"intermediate",
"grade",
")",
",",
"neuroendocrine",
"tumors",
"(",
"NET",
")"
] |
[
0,
0,
3,
3,
0,
3,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0
] |
NCT02454010
|
1:16:treatment,,
|
Prior radiation to > 30% of the red marrow or to maximal tolerable level for any organ
| 3
|
[
"Prior",
"radiation",
"to",
">",
"30",
"%",
"of",
"the",
"red",
"marrow",
"or",
"to",
"maximal",
"tolerable",
"level",
"for",
"any",
"organ"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03104699
|
112:146:cancer,154:164:treatment,165:174:treatment,197:208:treatment
|
Subjects must have had one prior systemic chemotherapeutic regimen for management of persistent, recurrent, or metastatic carcinoma of the cervix (e.g., paclitaxel/cisplatin, paclitaxel/cisplatin/bevacizumab)
| 3
|
[
"Subjects",
"must",
"have",
"had",
"one",
"prior",
"systemic",
"chemotherapeutic",
"regimen",
"for",
"management",
"of",
"persistent",
",",
"recurrent",
",",
"or",
"metastatic",
"carcinoma",
"of",
"the",
"cervix",
"(",
"e.g.",
",",
"paclitaxel/cisplatin",
",",
"paclitaxel/cisplatin/bevacizumab",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
1,
0,
1,
0
] |
NCT01623167
|
15:30:chronic_disease,
|
Evidence of a clonal disorder on cytogenetics performed within 12 weeks of study entry
| 3
|
[
"Evidence",
"of",
"a",
"clonal",
"disorder",
"on",
"cytogenetics",
"performed",
"within",
"12",
"weeks",
"of",
"study",
"entry"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02451215
|
1:22:cancer
|
Germ cell tumor (GCT)
| 3
|
[
"Germ",
"cell",
"tumor",
"(",
"GCT",
")"
] |
[
3,
3,
3,
3,
0,
0
] |
NCT03081390
|
1:9:chronic_disease,
|
Migraine headaches, or headaches other than tension-type headaches with a frequency of 1 or fewer days per month
| 3
|
[
"Migraine",
"headaches",
",",
"or",
"headaches",
"other",
"than",
"tension-type",
"headaches",
"with",
"a",
"frequency",
"of",
"1",
"or",
"fewer",
"days",
"per",
"month"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02639065
|
,,19:35:cancer
|
Gleason score ≤ 7 prostate cancers
| 3
|
[
"Gleason",
"score",
"≤",
"7",
"prostate",
"cancers"
] |
[
0,
0,
0,
0,
3,
3
] |
NCT01730118
|
14:33:chronic_disease,52:61:treatment,121:135:cancer
|
Recurrent or progressive disease on prior standard therapies with known clinical benefit with the exception of adjuvant bladder cancer population
| 3
|
[
"Recurrent",
"or",
"progressive",
"disease",
"on",
"prior",
"standard",
"therapies",
"with",
"known",
"clinical",
"benefit",
"with",
"the",
"exception",
"of",
"adjuvant",
"bladder",
"cancer",
"population"
] |
[
0,
0,
2,
2,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0
] |
NCT02320292
|
23:38:treatment,63:71:cancer,96:106:treatment,
|
patients who received corticosteroids for diseases other than lymphoma are eligible as long as prednisone dose is =< 10 mg/day
| 3
|
[
"patients",
"who",
"received",
"corticosteroids",
"for",
"diseases",
"other",
"than",
"lymphoma",
"are",
"eligible",
"as",
"long",
"as",
"prednisone",
"dose",
"is",
"=",
"<",
"10",
"mg/day"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02468453
|
25:44:treatment,48:71:treatment,62:71:treatment,
|
Subject has undergone a facial dermabrasion or chemical peel treatment within 3 months of treatment or during the study (if face is treated)
| 3
|
[
"Subject",
"has",
"undergone",
"a",
"facial",
"dermabrasion",
"or",
"chemical",
"peel",
"treatment",
"within",
"3",
"months",
"of",
"treatment",
"or",
"during",
"the",
"study",
"(",
"if",
"face",
"is",
"treated",
")"
] |
[
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02128802
|
33:54:treatment
|
All other criteria required for renal transplantation
| 3
|
[
"All",
"other",
"criteria",
"required",
"for",
"renal",
"transplantation"
] |
[
0,
0,
0,
0,
0,
1,
1
] |
NCT02145351
|
1:23:chronic_disease
|
Severe hepatic disease
| 3
|
[
"Severe",
"hepatic",
"disease"
] |
[
2,
2,
2
] |
NCT01793519
|
,36:46:treatment,
|
Treated with greater than 10 mg of prednisone (or equivalent) daily in the last 6 months
| 3
|
[
"Treated",
"with",
"greater",
"than",
"10",
"mg",
"of",
"prednisone",
"(",
"or",
"equivalent",
")",
"daily",
"in",
"the",
"last",
"6",
"months"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02905578
|
75:89:cancer
|
Pathologic diagnosis (cell samples, biopsy, brushing, surgical sample) of adenocarcinoma of the pancreas
| 3
|
[
"Pathologic",
"diagnosis",
"(",
"cell",
"samples",
",",
"biopsy",
",",
"brushing",
",",
"surgical",
"sample",
")",
"of",
"adenocarcinoma",
"of",
"the",
"pancreas"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0
] |
NCT02407171
|
14:25:chronic_disease,33:38:chronic_disease,52:63:chronic_disease,71:74:chronic_disease,75:78:treatment
|
known active Hepatitis B (e.g., HBsAg reactive) or Hepatitis C (e.g., HCV RNA [qualitative] is detected)
| 3
|
[
"known",
"active",
"Hepatitis",
"B",
"(",
"e.g.",
",",
"HBsAg",
"reactive",
")",
"or",
"Hepatitis",
"C",
"(",
"e.g.",
",",
"HCV",
"RNA",
"[",
"qualitative",
"]",
"is",
"detected",
")"
] |
[
0,
0,
2,
2,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
1,
0,
0,
0,
0,
0,
0
] |
NCT02469662
|
25:53:chronic_disease
|
Patient has significant ipsilateral hand dysfunction
| 3
|
[
"Patient",
"has",
"significant",
"ipsilateral",
"hand",
"dysfunction"
] |
[
0,
0,
0,
2,
2,
2
] |
NCT01989585
|
1:12:treatment,14:26:treatment,28:40:treatment,42:54:treatment,56:68:treatment
|
Antifungals: itraconazole, ketoconazole, posaconazole, voriconazole
| 3
|
[
"Antifungals",
":",
"itraconazole",
",",
"ketoconazole",
",",
"posaconazole",
",",
"voriconazole"
] |
[
1,
0,
1,
0,
1,
0,
1,
0,
1
] |
NCT01928576
|
5:19:cancer,48:66:treatment,71:75:treatment,169:179:treatment,183:194:treatment
|
All adenocarcinoma patients will be tested for ALK rearrangements and EGFR (Exon 19 Deletion and Exon 21 L8585R Substitution) mutations and must have been treated with prior EGFR or ALK therapy as well as a platinum containing doublet
| 3
|
[
"All",
"adenocarcinoma",
"patients",
"will",
"be",
"tested",
"for",
"ALK",
"rearrangements",
"and",
"EGFR",
"(",
"Exon",
"19",
"Deletion",
"and",
"Exon",
"21",
"L8585R",
"Substitution",
")",
"mutations",
"and",
"must",
"have",
"been",
"treated",
"with",
"prior",
"EGFR",
"or",
"ALK",
"therapy",
"as",
"well",
"as",
"a",
"platinum",
"containing",
"doublet"
] |
[
0,
3,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00875342
|
1:17:chronic_disease
|
Bipolar disorder
| 3
|
[
"Bipolar",
"disorder"
] |
[
2,
2
] |
NCT01505569
|
47:56:treatment,58:80:treatment,84:97:treatment,111:124:treatment,
|
Timing: patients must be fully recovered from radiation, induction chemotherapy or surgery prior to receiving consolidation, with minimum elapsed time of 2 weeks
| 3
|
[
"Timing",
":",
"patients",
"must",
"be",
"fully",
"recovered",
"from",
"radiation",
",",
"induction",
"chemotherapy",
"or",
"surgery",
"prior",
"to",
"receiving",
"consolidation",
",",
"with",
"minimum",
"elapsed",
"time",
"of",
"2",
"weeks"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02439450
|
28:41:treatment,59:71:treatment,90:106:cancer
|
Arm 6: Received front line immunotherapy (with or without chemotherapy) for incurable or metastatic NSCLC and did not progress clinically
| 3
|
[
"Arm",
"6",
":",
"Received",
"front",
"line",
"immunotherapy",
"(",
"with",
"or",
"without",
"chemotherapy",
")",
"for",
"incurable",
"or",
"metastatic",
"NSCLC",
"and",
"did",
"not",
"progress",
"clinically"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0
] |
NCT02589938
|
11:19:chronic_disease
|
Grade 4 - Fibrosis
| 3
|
[
"Grade",
"4",
"-",
"Fibrosis"
] |
[
0,
0,
0,
2
] |
NCT02226341
|
14:48:chronic_disease
|
Diagnosis of Systemic Lupus Erythematosus (SLE) by American College of Rheumatology (ACR)/SLICC criteria
| 3
|
[
"Diagnosis",
"of",
"Systemic",
"Lupus",
"Erythematosus",
"(",
"SLE",
")",
"by",
"American",
"College",
"of",
"Rheumatology",
"(",
"ACR",
")",
"/SLICC",
"criteria"
] |
[
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02374333
|
1:28:cancer,38:52:cancer,95:111:cancer,118:133:treatment,155:169:treatment
|
Diffuse large cell lymphoma or other high-grade NHL, previously identified as CD19+ including residual disease after primary therapy and not eligible for autologous SCT
| 3
|
[
"Diffuse",
"large",
"cell",
"lymphoma",
"or",
"other",
"high-grade",
"NHL",
",",
"previously",
"identified",
"as",
"CD19+",
"including",
"residual",
"disease",
"after",
"primary",
"therapy",
"and",
"not",
"eligible",
"for",
"autologous",
"SCT"
] |
[
3,
3,
3,
3,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
3,
3,
0,
1,
1,
0,
0,
0,
0,
1,
1
] |
NCT02219555
|
1:9:chronic_disease
|
Diabetes
| 3
|
[
"Diabetes"
] |
[
2
] |
NCT03145298
|
12:27:chronic_disease
|
history of viral hepatitis
| 3
|
[
"history",
"of",
"viral",
"hepatitis"
] |
[
0,
0,
2,
2
] |
NCT01920737
|
1:30:cancer
|
Mature B-cell (Burkitt's) ALL
| 3
|
[
"Mature",
"B-cell",
"(",
"Burkitt",
"'s",
")",
"ALL"
] |
[
3,
3,
3,
3,
0,
0,
0
] |
NCT02520791
|
38:71:cancer,91:132:cancer,,176:183:treatment
|
Patients with confirmed diagnosis of peripheral T-cell lymphoma (PTCL) follicular type or angioimmunoblastic T-cell lymphoma (AITL) that is refractory to at least one line of therapy
| 3
|
[
"Patients",
"with",
"confirmed",
"diagnosis",
"of",
"peripheral",
"T-cell",
"lymphoma",
"(",
"PTCL",
")",
"follicular",
"type",
"or",
"angioimmunoblastic",
"T-cell",
"lymphoma",
"(",
"AITL",
")",
"that",
"is",
"refractory",
"to",
"at",
"least",
"one",
"line",
"of",
"therapy"
] |
[
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02822378
|
15:38:chronic_disease
|
significantly impaired renal function
| 3
|
[
"significantly",
"impaired",
"renal",
"function"
] |
[
0,
2,
2,
2
] |
NCT02361944
|
16:20:treatment,25:44:treatment
|
Current use of hemo- or peritoneal dialysis
| 3
|
[
"Current",
"use",
"of",
"hemo-",
"or",
"peritoneal",
"dialysis"
] |
[
0,
0,
0,
1,
0,
1,
1
] |
NCT03008070
|
1:5:chronic_disease,93:98:chronic_disease,,,244:256:treatment,
|
NASH histological diagnosis according to the currently accepted definition of both EASL and AASLD, requiring the combined presence of steatosis (any degree ≥ 5%) + lobular inflammation of any degree + liver cell ballooning of any amount, on a liver biopsy performed ≤ 6 months before screening in the study or at screening and confirmed by central reading during the screening period
| 3
|
[
"NASH",
"histological",
"diagnosis",
"according",
"to",
"the",
"currently",
"accepted",
"definition",
"of",
"both",
"EASL",
"and",
"AASLD",
",",
"requiring",
"the",
"combined",
"presence",
"of",
"steatosis",
"(",
"any",
"degree",
"≥",
"5",
"%",
")",
"+",
"lobular",
"inflammation",
"of",
"any",
"degree",
"+",
"liver",
"cell",
"ballooning",
"of",
"any",
"amount",
",",
"on",
"a",
"liver",
"biopsy",
"performed",
"≤",
"6",
"months",
"before",
"screening",
"in",
"the",
"study",
"or",
"at",
"screening",
"and",
"confirmed",
"by",
"central",
"reading",
"during",
"the",
"screening",
"period"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02312596
|
18:37:chronic_disease
|
A full thickness diabetic foot ulcer with a viable wound bed
| 3
|
[
"A",
"full",
"thickness",
"diabetic",
"foot",
"ulcer",
"with",
"a",
"viable",
"wound",
"bed"
] |
[
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT01434316
|
14:34:chronic_disease,76:92:chronic_disease,106:130:chronic_disease,132:156:chronic_disease,161:198:chronic_disease
|
Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, or psychiatric illness/social situations that would limit compliance with study requirements
| 3
|
[
"Uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
"ongoing",
"or",
"active",
"infection",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"or",
"psychiatric",
"illness/social",
"situations",
"that",
"would",
"limit",
"compliance",
"with",
"study",
"requirements"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01942018
|
1:21:chronic_disease
|
Esophageal stricture
| 3
|
[
"Esophageal",
"stricture"
] |
[
2,
2
] |
NCT02560623
|
28:57:cancer
|
Patients with a history of esophageal squamous dysplasia
| 3
|
[
"Patients",
"with",
"a",
"history",
"of",
"esophageal",
"squamous",
"dysplasia"
] |
[
0,
0,
0,
0,
0,
3,
3,
3
] |
NCT01872975
|
36:68:cancer
|
patients with margins positive for lobular carcinoma in situ [LCIS] are eligible without additional resection
| 3
|
[
"patients",
"with",
"margins",
"positive",
"for",
"lobular",
"carcinoma",
"in",
"situ",
"[",
"LCIS",
"]",
"are",
"eligible",
"without",
"additional",
"resection"
] |
[
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02562430
|
1:16:chronic_disease
|
Serious suicide
| 3
|
[
"Serious",
"suicide"
] |
[
2,
2
] |
NCT02387905
|
50:66:cancer,71:83:treatment,96:112:cancer
|
All patients must have histologic proof of solid tumor malignancy and radiographic evidence of spine metastasis
| 3
|
[
"All",
"patients",
"must",
"have",
"histologic",
"proof",
"of",
"solid",
"tumor",
"malignancy",
"and",
"radiographic",
"evidence",
"of",
"spine",
"metastasis"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
1,
0,
0,
3,
3
] |
NCT02503722
|
5:27:treatment
|
any concomitant medication known to prolong the QT interval
| 3
|
[
"any",
"concomitant",
"medication",
"known",
"to",
"prolong",
"the",
"QT",
"interval"
] |
[
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02336451
|
45:63:chronic_disease,74:104:chronic_disease,108:130:chronic_disease
|
Patient has other severe, acute, or chronic medical conditions including uncontrolled diabetes mellitus or psychiatric conditions or laboratory abnormalities that in the opinion of the investigator may increase the risk associated with study participation, or that may interfere with the interpretation of study results
| 3
|
[
"Patient",
"has",
"other",
"severe",
",",
"acute",
",",
"or",
"chronic",
"medical",
"conditions",
"including",
"uncontrolled",
"diabetes",
"mellitus",
"or",
"psychiatric",
"conditions",
"or",
"laboratory",
"abnormalities",
"that",
"in",
"the",
"opinion",
"of",
"the",
"investigator",
"may",
"increase",
"the",
"risk",
"associated",
"with",
"study",
"participation",
",",
"or",
"that",
"may",
"interfere",
"with",
"the",
"interpretation",
"of",
"study",
"results"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01821690
|
14:23:treatment
|
Ingestion of buspirone during the month prior to enrollment
| 3
|
[
"Ingestion",
"of",
"buspirone",
"during",
"the",
"month",
"prior",
"to",
"enrollment"
] |
[
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02780401
|
28:79:treatment,83:101:treatment,,122:138:treatment
|
Willing to not undergo any elective surgical procedure with general anesthesia or conscious sedation through the 1 month post-vaccination visit
| 3
|
[
"Willing",
"to",
"not",
"undergo",
"any",
"elective",
"surgical",
"procedure",
"with",
"general",
"anesthesia",
"or",
"conscious",
"sedation",
"through",
"the",
"1",
"month",
"post-vaccination",
"visit"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
0,
1,
1,
0,
0,
0,
0,
1,
0
] |
NCT02154568
|
1:4:treatment
|
CXR normal except hyperinflation
| 3
|
[
"CXR",
"normal",
"except",
"hyperinflation"
] |
[
1,
0,
0,
0
] |
NCT01419561
|
1:7:chronic_disease,9:17:chronic_disease,19:33:chronic_disease,37:56:chronic_disease
|
Nausea, anorexia, abdominal pain or altered bowel habit
| 3
|
[
"Nausea",
",",
"anorexia",
",",
"abdominal",
"pain",
"or",
"altered",
"bowel",
"habit"
] |
[
2,
0,
2,
0,
2,
2,
0,
2,
2,
2
] |
NCT02900469
|
52:65:chronic_disease,69:93:chronic_disease,117:144:chronic_disease,160:182:treatment
|
Patients have prior history or current evidence of osteonecrosis or osteomyelitis of the jaw, evidence of untreated local gum or oral infection, or non-healed dental or oral surgery
| 3
|
[
"Patients",
"have",
"prior",
"history",
"or",
"current",
"evidence",
"of",
"osteonecrosis",
"or",
"osteomyelitis",
"of",
"the",
"jaw",
",",
"evidence",
"of",
"untreated",
"local",
"gum",
"or",
"oral",
"infection",
",",
"or",
"non-healed",
"dental",
"or",
"oral",
"surgery"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
2,
2,
0,
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
1,
1,
1,
1
] |
NCT02165449
|
53:70:treatment
|
Have no contraindications to an adjunctive trial of ketamine infusion
| 3
|
[
"Have",
"no",
"contraindications",
"to",
"an",
"adjunctive",
"trial",
"of",
"ketamine",
"infusion"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01620216
|
1:14:treatment,16:27:treatment,44:60:chronic_disease
|
Major surgery, open biopsy, or significant traumatic injury
| 3
|
[
"Major",
"surgery",
",",
"open",
"biopsy",
",",
"or",
"significant",
"traumatic",
"injury"
] |
[
1,
1,
0,
1,
1,
0,
0,
0,
2,
2
] |
NCT02481245
|
40:65:chronic_disease,76:84:chronic_disease,96:113:chronic_disease,115:130:chronic_disease,139:145:chronic_disease,161:172:chronic_disease
|
Suspected or known clinically unstable systemic medical disorder including epilepsy, untreated endocrine disease, unstable angina, recent ulcers or significant esophagitis
| 3
|
[
"Suspected",
"or",
"known",
"clinically",
"unstable",
"systemic",
"medical",
"disorder",
"including",
"epilepsy",
",",
"untreated",
"endocrine",
"disease",
",",
"unstable",
"angina",
",",
"recent",
"ulcers",
"or",
"significant",
"esophagitis"
] |
[
0,
0,
0,
0,
2,
2,
2,
2,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
0,
0,
2
] |
NCT02047474
|
4:19:treatment,21:33:treatment,35:53:treatment,58:70:treatment,87:104:cancer
|
No prior treatment (chemotherapy, biological therapy, or radiotherapy) for resectable pancreatic cancer
| 3
|
[
"No",
"prior",
"treatment",
"(",
"chemotherapy",
",",
"biological",
"therapy",
",",
"or",
"radiotherapy",
")",
"for",
"resectable",
"pancreatic",
"cancer"
] |
[
0,
1,
1,
0,
1,
0,
1,
1,
0,
0,
1,
0,
0,
0,
3,
3
] |
NCT01366612
|
7:34:cancer
|
other myeloproliferative disorder
| 3
|
[
"other",
"myeloproliferative",
"disorder"
] |
[
0,
3,
3
] |
NCT02533882
|
1:21:chronic_disease,,
|
Cognitive impairment (Mini-Mental State Exam score < 24)
| 3
|
[
"Cognitive",
"impairment",
"(",
"Mini-Mental",
"State",
"Exam",
"score",
"<",
"24",
")"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02744677
|
1:11:chronic_disease,,,35:41:chronic_disease,,,58:74:chronic_disease,,,118:141:chronic_disease
|
Leukopenia (WBC < 2000 cells/µL), anemia (Hgb < 7 g/dL), thrombocytopenia (Platelets < 50,000 cells/µL) or any known blood clotting disorder
| 3
|
[
"Leukopenia",
"(",
"WBC",
"<",
"2000",
"cells/µL",
")",
",",
"anemia",
"(",
"Hgb",
"<",
"7",
"g/dL",
")",
",",
"thrombocytopenia",
"(",
"Platelets",
"<",
"50,000",
"cells/µL",
")",
"or",
"any",
"known",
"blood",
"clotting",
"disorder"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT00432094
|
,,,,174:188:treatment
|
Male and female patients of reproductive potential must use an approved contraceptive method if appropriate (for example, intrauterine device [IUD], birth control pills, or barrier device) during and for the duration of study participation
| 3
|
[
"Male",
"and",
"female",
"patients",
"of",
"reproductive",
"potential",
"must",
"use",
"an",
"approved",
"contraceptive",
"method",
"if",
"appropriate",
"(",
"for",
"example",
",",
"intrauterine",
"device",
"[",
"IUD",
"]",
",",
"birth",
"control",
"pills",
",",
"or",
"barrier",
"device",
")",
"during",
"and",
"for",
"the",
"duration",
"of",
"study",
"participation"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02774421
|
35:53:treatment
|
who are currently receiving other anti-cancer agents
| 3
|
[
"who",
"are",
"currently",
"receiving",
"other",
"anti-cancer",
"agents"
] |
[
0,
0,
0,
0,
0,
1,
1
] |
NCT02393885
|
14:24:cancer,63:81:treatment,85:103:treatment
|
Pre-existing esophageal condition that required (or requires) endoscopic therapy or surgical treatment
| 3
|
[
"Pre-existing",
"esophageal",
"condition",
"that",
"required",
"(",
"or",
"requires",
")",
"endoscopic",
"therapy",
"or",
"surgical",
"treatment"
] |
[
0,
3,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1
] |
NCT02536794
|
29:59:treatment
|
Patients who are taking any herbal (alternative) medicines are NOT eligible for participation
| 3
|
[
"Patients",
"who",
"are",
"taking",
"any",
"herbal",
"(",
"alternative",
")",
"medicines",
"are",
"NOT",
"eligible",
"for",
"participation"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT00857207
|
34:45:treatment,87:102:treatment,104:111:treatment,113:128:treatment,133:147:treatment
|
Changes within the past month of medications known to affect cognitive functions e.g. benzodiazepines, opioids, antidepressants and antipsychotics
| 3
|
[
"Changes",
"within",
"the",
"past",
"month",
"of",
"medications",
"known",
"to",
"affect",
"cognitive",
"functions",
"e.g",
".",
"benzodiazepines",
",",
"opioids",
",",
"antidepressants",
"and",
"antipsychotics"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1
] |
NCT02178709
|
,,,151:161:treatment
|
Women of childbearing potential definition (WOCBP) must have a negative serum or urine pregnancy test performed within 14 days prior to initiation of FOLFIRINOX
| 3
|
[
"Women",
"of",
"childbearing",
"potential",
"definition",
"(",
"WOCBP",
")",
"must",
"have",
"a",
"negative",
"serum",
"or",
"urine",
"pregnancy",
"test",
"performed",
"within",
"14",
"days",
"prior",
"to",
"initiation",
"of",
"FOLFIRINOX"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02016781
|
1:46:chronic_disease
|
Refractory anemia with excess blasts (RAEB-1)
| 3
|
[
"Refractory",
"anemia",
"with",
"excess",
"blasts",
"(",
"RAEB-1",
")"
] |
[
2,
2,
2,
2,
2,
2,
0,
0
] |
NCT02354703
|
34:50:chronic_disease,58:69:chronic_disease,71:78:chronic_disease,82:101:chronic_disease,108:122:chronic_disease,124:133:chronic_disease,135:151:chronic_disease,153:162:chronic_disease,164:176:chronic_disease,178:188:chronic_disease,190:200:chronic_disease,205:226:chronic_disease
|
Clinically significant, unstable physical illness (e.g., hematologic, hepatic or renal insufficiency, or a cardiovascular, pulmonary, gastrointestinal, endocrine, neurological, infectious, neoplastic, or metabolic disturbance)
| 3
|
[
"Clinically",
"significant",
",",
"unstable",
"physical",
"illness",
"(",
"e.g.",
",",
"hematologic",
",",
"hepatic",
"or",
"renal",
"insufficiency",
",",
"or",
"a",
"cardiovascular",
",",
"pulmonary",
",",
"gastrointestinal",
",",
"endocrine",
",",
"neurological",
",",
"infectious",
",",
"neoplastic",
",",
"or",
"metabolic",
"disturbance",
")"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
0,
2,
0,
2,
2,
0,
0,
0,
2,
0,
2,
0,
2,
0,
2,
0,
2,
0,
2,
0,
2,
0,
0,
2,
2,
0
] |
NCT03143153
|
30:46:chronic_disease
|
Any positive test result for hepatitis B or C indicating acute or chronic infection and/or detectable virus
| 3
|
[
"Any",
"positive",
"test",
"result",
"for",
"hepatitis",
"B",
"or",
"C",
"indicating",
"acute",
"or",
"chronic",
"infection",
"and/or",
"detectable",
"virus"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02875301
|
21:24:treatment
|
Eligible to undergo MRI
| 3
|
[
"Eligible",
"to",
"undergo",
"MRI"
] |
[
0,
0,
0,
1
] |
NCT02422641
|
21:24:treatment
|
Contraindication to MRI
| 3
|
[
"Contraindication",
"to",
"MRI"
] |
[
0,
0,
1
] |
NCT02418195
|
1:10:cancer
|
Pregnancy
| 3
|
[
"Pregnancy"
] |
[
3
] |
NCT01861106
|
138:145:chronic_disease
|
No mutation in GATA2, or in the case where the mutation in GATA2 has not been identified, but the recipient has the clinical syndrome of MonoMAC, the donor is required to have no clinical evidence of MonoMA
| 3
|
[
"No",
"mutation",
"in",
"GATA2",
",",
"or",
"in",
"the",
"case",
"where",
"the",
"mutation",
"in",
"GATA2",
"has",
"not",
"been",
"identified",
",",
"but",
"the",
"recipient",
"has",
"the",
"clinical",
"syndrome",
"of",
"MonoMAC",
",",
"the",
"donor",
"is",
"required",
"to",
"have",
"no",
"clinical",
"evidence",
"of",
"MonoMA"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02654236
|
18:81:treatment,
|
Participation in another investigational drug, biologic, or medical device trial within 30 days prior to Screening
| 3
|
[
"Participation",
"in",
"another",
"investigational",
"drug",
",",
"biologic",
",",
"or",
"medical",
"device",
"trial",
"within",
"30",
"days",
"prior",
"to",
"Screening"
] |
[
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02159027
|
32:49:chronic_disease,64:84:treatment,91:138:treatment
|
Active or inadequately treated tuberculosis (TB) infection, or inadequate treatment for a positive purified protein derivative (PPD) test
| 3
|
[
"Active",
"or",
"inadequately",
"treated",
"tuberculosis",
"(",
"TB",
")",
"infection",
",",
"or",
"inadequate",
"treatment",
"for",
"a",
"positive",
"purified",
"protein",
"derivative",
"(",
"PPD",
")",
"test"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0
] |
NCT02132130
|
36:48:chronic_disease
|
Non-fluctuating severe-to-profound hearing loss is required for the study ear
| 3
|
[
"Non-fluctuating",
"severe-to-profound",
"hearing",
"loss",
"is",
"required",
"for",
"the",
"study",
"ear"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02913612
|
12:42:chronic_disease
|
History of Reactive Airways Disease (RAD)
| 3
|
[
"History",
"of",
"Reactive",
"Airways",
"Disease",
"(",
"RAD",
")"
] |
[
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT02048332
|
8:18:chronic_disease,,
|
Active acute GVHD grades II-IV
| 3
|
[
"Active",
"acute",
"GVHD",
"grades",
"II-IV"
] |
[
0,
2,
2,
0,
0
] |
NCT03038620
|
1:8:chronic_disease,26:50:chronic_disease,57:73:chronic_disease
|
Obesity induced by other endocrinologic disorders (e.g. Cushing Syndrome)
| 3
|
[
"Obesity",
"induced",
"by",
"other",
"endocrinologic",
"disorders",
"(",
"e.g",
".",
"Cushing",
"Syndrome",
")"
] |
[
2,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
0
] |
NCT02464878
|
1:20:chronic_disease
|
portal hypertension
| 3
|
[
"portal",
"hypertension"
] |
[
2,
2
] |
NCT02266784
|
36:40:chronic_disease
|
For Control Group: NO diagnosis of ADHD as determined by clinician administered CAADID and clinical interview
| 3
|
[
"For",
"Control",
"Group",
":",
"NO",
"diagnosis",
"of",
"ADHD",
"as",
"determined",
"by",
"clinician",
"administered",
"CAADID",
"and",
"clinical",
"interview"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00969332
|
1:27:chronic_disease
|
Fatal chromosomal disorder
| 3
|
[
"Fatal",
"chromosomal",
"disorder"
] |
[
2,
2,
2
] |
NCT02207465
|
23:33:cancer,,70:88:cancer,92:112:cancer
|
Prior or simultaneous malignancy within the past 2 years (other than cutaneous squamous or basal cell carcinoma
| 3
|
[
"Prior",
"or",
"simultaneous",
"malignancy",
"within",
"the",
"past",
"2",
"years",
"(",
"other",
"than",
"cutaneous",
"squamous",
"or",
"basal",
"cell",
"carcinoma"
] |
[
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
3,
3,
3
] |
NCT02301663
|
12:25:allergy_name
|
Allergy to animal dander
| 3
|
[
"Allergy",
"to",
"animal",
"dander"
] |
[
0,
0,
4,
4
] |
NCT02946892
|
22:53:chronic_disease
|
significant systemic ventricular outflow obstruction
| 3
|
[
"significant",
"systemic",
"ventricular",
"outflow",
"obstruction"
] |
[
0,
0,
2,
2,
2
] |
NCT02719327
|
22:42:treatment
|
Current use of other investigational drug
| 3
|
[
"Current",
"use",
"of",
"other",
"investigational",
"drug"
] |
[
0,
0,
0,
0,
1,
1
] |
NCT02734134
|
32:42:treatment
|
A sinus communicating with the prosthesis
| 3
|
[
"A",
"sinus",
"communicating",
"with",
"the",
"prosthesis"
] |
[
0,
0,
0,
0,
0,
1
] |
NCT02543866
|
15:41:treatment,84:98:treatment,112:119:chronic_disease,181:192:chronic_disease
|
Presence of a ventriculoperitoneal shunt or other intrabdominal device, receipt of renal dialysis, presence of ascites, or other conditions/devices that would increase the risk of peritonitis
| 3
|
[
"Presence",
"of",
"a",
"ventriculoperitoneal",
"shunt",
"or",
"other",
"intrabdominal",
"device",
",",
"receipt",
"of",
"renal",
"dialysis",
",",
"presence",
"of",
"ascites",
",",
"or",
"other",
"conditions/devices",
"that",
"would",
"increase",
"the",
"risk",
"of",
"peritonitis"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02152956
|
1:26:treatment
|
Adjuvant hormonal therapy
| 3
|
[
"Adjuvant",
"hormonal",
"therapy"
] |
[
1,
1,
1
] |
NCT01356290
|
17:39:chronic_disease,66:73:treatment,79:100:chronic_disease
|
Any significant cardiovascular disease not controled by standard therapy e.g. systemic hypertension
| 3
|
[
"Any",
"significant",
"cardiovascular",
"disease",
"not",
"controled",
"by",
"standard",
"therapy",
"e.g",
".",
"systemic",
"hypertension"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
1,
0,
0,
2,
2
] |
NCT02511301
|
5:25:chronic_disease,
|
Any trauma to the breast within the last 90 days
| 3
|
[
"Any",
"trauma",
"to",
"the",
"breast",
"within",
"the",
"last",
"90",
"days"
] |
[
0,
2,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02366819
|
1:14:treatment,
|
Major surgery within 4 weeks
| 3
|
[
"Major",
"surgery",
"within",
"4",
"weeks"
] |
[
1,
1,
0,
0,
0
] |
NCT02393794
|
1:10:treatment,19:29:cancer,,67:82:treatment
|
Radiation to bony metastases is allowed ≥ 14 days before starting study treatment
| 3
|
[
"Radiation",
"to",
"bony",
"metastases",
"is",
"allowed",
"≥",
"14",
"days",
"before",
"starting",
"study",
"treatment"
] |
[
1,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02489539
|
22:36:chronic_disease
|
Severely tortuous or stenotic iliac
| 3
|
[
"Severely",
"tortuous",
"or",
"stenotic",
"iliac"
] |
[
0,
0,
0,
2,
2
] |
NCT01061515
|
48:59:allergy_name,61:72:allergy_name,74:78:allergy_name,82:94:allergy_name
|
Prior history of hypersensitivity reactions to oxaliplatin, bevacizumab, 5-FU or capecitabine
| 3
|
[
"Prior",
"history",
"of",
"hypersensitivity",
"reactions",
"to",
"oxaliplatin",
",",
"bevacizumab",
",",
"5-FU",
"or",
"capecitabine"
] |
[
0,
0,
0,
0,
0,
0,
4,
0,
4,
0,
4,
0,
4
] |
NCT02536794
|
14:23:chronic_disease,25:30:chronic_disease,35:54:chronic_disease
|
Uncontrolled pulmonary, renal, or hepatic dysfunction
| 3
|
[
"Uncontrolled",
"pulmonary",
",",
"renal",
",",
"or",
"hepatic",
"dysfunction"
] |
[
0,
2,
0,
2,
0,
0,
2,
2
] |
NCT02158858
|
1:37:treatment
|
Prior treatment with a BET inhibitor
| 3
|
[
"Prior",
"treatment",
"with",
"a",
"BET",
"inhibitor"
] |
[
1,
1,
1,
1,
1,
1
] |
NCT01326715
|
,10:12:chronic_disease
|
Up to 15 MS patients
| 3
|
[
"Up",
"to",
"15",
"MS",
"patients"
] |
[
0,
0,
0,
2,
0
] |
NCT02097121
|
8:24:treatment,
|
Use of anticholinergics or other medications to treat OAB symptoms within 7 days
| 3
|
[
"Use",
"of",
"anticholinergics",
"or",
"other",
"medications",
"to",
"treat",
"OAB",
"symptoms",
"within",
"7",
"days"
] |
[
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03181893
|
6:8:chronic_disease
|
Post DM diagnosis; standard of care workup for DM must have been completed prior to entry into this research study
| 3
|
[
"Post",
"DM",
"diagnosis",
";",
"standard",
"of",
"care",
"workup",
"for",
"DM",
"must",
"have",
"been",
"completed",
"prior",
"to",
"entry",
"into",
"this",
"research",
"study"
] |
[
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02451423
|
1:15:treatment,
|
Major surgical procedure other than for diagnosis within 28 days prior to Cycle 1, Day 1
| 3
|
[
"Major",
"surgical",
"procedure",
"other",
"than",
"for",
"diagnosis",
"within",
"28",
"days",
"prior",
"to",
"Cycle",
"1",
",",
"Day",
"1"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02118610
|
38:47:treatment,93:106:chronic_disease,158:174:treatment,190:193:chronic_disease,195:209:chronic_disease,211:235:chronic_disease,237:253:chronic_disease,265:280:chronic_disease,314:337:chronic_disease,339:347:chronic_disease,385:402:chronic_disease,404:423:chronic_disease,425:453:chronic_disease,455:474:chronic_disease,476:490:chronic_disease,495:501:cancer
|
Medical condition whose pathology or treatment could alter the presentation or treatment of schizophrenia or significantly increase the risk associated with study medication. This includes HIV, kidney disease, congestive heart failure, pheochromocytoma, untreated hyperthyroidism, dehydration, fever, uncorrected congenital heart defect, seizures, electrolyte imbalance, uncontrolled diabetes mellitus, porphyria variegate, superventricular tachycardia, atrial fibrillation, cardiomyopathy, or cancer
| 3
|
[
"Medical",
"condition",
"whose",
"pathology",
"or",
"treatment",
"could",
"alter",
"the",
"presentation",
"or",
"treatment",
"of",
"schizophrenia",
"or",
"significantly",
"increase",
"the",
"risk",
"associated",
"with",
"study",
"medication",
".",
"This",
"includes",
"HIV",
",",
"kidney",
"disease",
",",
"congestive",
"heart",
"failure",
",",
"pheochromocytoma",
",",
"untreated",
"hyperthyroidism",
",",
"dehydration",
",",
"fever",
",",
"uncorrected",
"congenital",
"heart",
"defect",
",",
"seizures",
",",
"electrolyte",
"imbalance",
",",
"uncontrolled",
"diabetes",
"mellitus",
",",
"porphyria",
"variegate",
",",
"superventricular",
"tachycardia",
",",
"atrial",
"fibrillation",
",",
"cardiomyopathy",
",",
"or",
"cancer"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
2,
0,
2,
2,
0,
2,
2,
2,
0,
2,
0,
0,
2,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
2,
0,
2,
2,
0,
2,
0,
0,
3
] |
NCT02167958
|
1:28:cancer,
|
Acute Myelogeneous Leukemia in high risk CR1
| 3
|
[
"Acute",
"Myelogeneous",
"Leukemia",
"in",
"high",
"risk",
"CR1"
] |
[
3,
3,
3,
0,
0,
0,
0
] |
NCT02919436
|
40:51:allergy_name
|
Serious or life-threatening allergy to sulfa drugs
| 3
|
[
"Serious",
"or",
"life-threatening",
"allergy",
"to",
"sulfa",
"drugs"
] |
[
0,
0,
0,
0,
0,
4,
4
] |
NCT02401035
|
5:13:chronic_disease,51:59:treatment,61:74:treatment,79:88:treatment,90:102:treatment,104:114:treatment,118:128:treatment,130:141:treatment,147:164:treatment,181:188:treatment
|
Any disorder requiring chronic (every day) use of warfarin, carbamazepine, or phenytoin, methotrexate, atazanavir or nelfinavir, clopidogrel, and potent inhibitors and inducers of CYP2C19
| 3
|
[
"Any",
"disorder",
"requiring",
"chronic",
"(",
"every",
"day",
")",
"use",
"of",
"warfarin",
",",
"carbamazepine",
",",
"or",
"phenytoin",
",",
"methotrexate",
",",
"atazanavir",
"or",
"nelfinavir",
",",
"clopidogrel",
",",
"and",
"potent",
"inhibitors",
"and",
"inducers",
"of",
"CYP2C19"
] |
[
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
1,
1,
0,
0,
0,
1
] |
NCT02152956
|
1:9:cancer,
|
leukemia refractory to ≥ 2 induction attempts
| 3
|
[
"leukemia",
"refractory",
"to",
"≥",
"2",
"induction",
"attempts"
] |
[
3,
0,
0,
0,
0,
0,
0
] |
NCT02576301
|
,,,70:91:treatment
|
MDS - Marrow blasts must be > 5% and disease failed at least 1 prior hypomethylating agent
| 3
|
[
"MDS",
"-",
"Marrow",
"blasts",
"must",
"be",
">",
"5",
"%",
"and",
"disease",
"failed",
"at",
"least",
"1",
"prior",
"hypomethylating",
"agent"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02460692
|
,,,,108:128:chronic_disease
|
systolic blood pressure > 170 mm, diastolic blood pressure > 100 mm Recent injuries to the upper extremity Cognitive impairment
| 3
|
[
"systolic",
"blood",
"pressure",
">",
"170",
"mm",
",",
"diastolic",
"blood",
"pressure",
">",
"100",
"mm",
"Recent",
"injuries",
"to",
"the",
"upper",
"extremity",
"Cognitive",
"impairment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.